Legal Representation
Attorney
Jinggao LI
USPTO Deadlines
Next Deadline
1957 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-26)
Due Date
November 26, 2030
Grace Period Ends
May 26, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 26, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 26, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 19, 2024 | OTHE | I | CASE RETURNED TO EXAMINATION | Loading... |
| Aug 19, 2024 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Aug 15, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 15, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 15, 2024 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Aug 15, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Aug 15, 2024 | PCBG | O | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | Loading... |
| Aug 8, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Aug 8, 2024 | PGEX | O | PETITION GRANTED - EXTENSION REQUEST FILED | Loading... |
| Jul 22, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jul 11, 2024 | PILM | I | PETITION INQUIRY LETTER ISSUED | Loading... |
| Jul 10, 2024 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Jun 6, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 5, 2024 | 44EP | I | 44(e) PETITION - RECEIVED | Loading... |
| Jun 5, 2024 | TPAD | I | TEAS PETITION TO AMEND BASIS RECEIVED | Loading... |
| Nov 24, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 22, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 22, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 22, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 6, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 11, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 11, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 22, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 2, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 2, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 2, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 2, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 2, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 22, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 21, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 5, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; Medicines for alleviating constipation; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders
Additional Information
Design Mark
The mark consists of the stylized wording "TransThera" with the stylized letter "n" having an elongated right side and a design with stylized leaves above, a curved line above the middle of the mark, and with four Chinese characters below the stylized wording that transliterate to "Yao Jie An Kang".
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording TransThera has no meaning in a foreign language.
Other
The non-Latin characters in the mark transliterate to Yao Jie An Kang and this means medicine, fast, safe and healthy in English.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YAO JIE AN KANG"